Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Thrombosis Drugs market size was valued at USD 40717.14 Million in 2022 and will reach USD 70149.43 Million in 2028, with a CAGR of 9.49% during 2022-2028.
Thrombosis drugs can help thin the blood and help dissolve blood clots. It can also slow down the formation of blood clots and help treat thrombotic diseases.
Influence of COVID-19 Outbreak on Thrombosis Drugs Industry Development
Due to the global outbreak of COVID-19, many countries have adopted strict lockdown measures, and many companies have adopted home office work. For the thrombosis drug industry, COVID-19 has affected the supply chain and industrial chain to a certain extent. COVID-19 may have affected the supply of upstream raw materials. At the same time, working from home and many pharmaceutical industries have shifted their research focus to the treatment of COVID-19, resulting in a shortage of professionals in the thrombosis drug industry. In addition, because the virus may spread through the logistics and transportation links, the inspection of logistics is stricter, which slows down the logistics and affects the delivery time and production cycle of thrombosis drugs.
Due to the COVID-19 lockdown measures, people have reduced the number of outings. Sedentary and lack of exercise are particularly noticeable during the COVID-19 lockdown. When a person accumulates blood during periods of inactivity, deep vein thrombosis can form and thicken into a blood clot. It is more likely to occur in the lower part of the body, but it may also occur in the arms or other areas. In severe cases, it may even form a pulmonary embolism. Therefore, during the COVID-19 blockade, people need to pay more attention to exercise at home, otherwise the risk of thrombosis may increase.
Drivers
Thrombosis is an abnormal blood clot in an artery or vein. Thrombosis drugs are used to prevent or treat blood clots that can cause different thrombotic events. The North American market occupies an important position in the thrombosis drug industry.
First of all, North America has a developed economy and attracts immigrants from all over the world. At the same time, the population of North America is aging. Coupled with the fast-paced lifestyle and eating habits in North America, the number of cardiovascular diseases and obesity in North America has increased rapidly. These diseases increase the risk of thrombosis, which promotes the development of the thrombosis drug industry in North America.
In addition, North America is the most economically and technologically developed region, with high income and consumption levels of residents. Coupled with the health care system and complete infrastructure, it is conducive to reimbursement of various thrombosis expenses and promotes the North American market. At the same time, the North American region has always attracted technical personnel from various industries, so that the region has an excellent talent pool to support the development of the industry. It is expected that the thrombosis drug industry in North America will continue to develop.
Region Overview:
Europe had the highest growth rate of all regions.
Company Overview:
Bayer AG is one of the major players operating in the Thrombosis Drugs market, holding a share of 16.21% in 2021.
Bayer AG manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
Bristol-Myers Squibb Company is a global biopharmaceutical company. Bristol Myers Squibb focuses on products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
Segmentation Overview:
Among different product types, Factor Xa Inhibitor segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Deep Vein Thrombosis segment occupied the biggest share from 2017 to 2022.
The Thrombosis Drugs market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Thrombosis Drugs market covered in Chapter 4:
LEO Pharma
Aspen Pharmacare Holdings Limited
Bayer AG
Chiesi
Boehringer Ingelheim GmbH
Sanofi SA
Daiichi Sankyo
Bristol-Myers Squibb
AstraZeneca PLC
Johnson & Johnson
ANGDE
Pfizer Inc.
In Chapter 12 and Chapter 14.1, on the basis of types, the Thrombosis Drugs market from 2018 to 2028 is primarily split into:
Factor Xa Inhibitor
Low Molecular Weight Heparin
P2Y12 Platelet Inhibitor
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Thrombosis Drugs market from 2018 to 2028 covers:
Pulmonary Embolism
Atrial Fibrillation
Deep Vein Thrombosis
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Thrombosis Drugs market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Thrombosis Drugs market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Thrombosis Drugs industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Thrombosis Drugs industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Thrombosis Drugs market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Thrombosis Drugs market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Thrombosis Drugs market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Thrombosis Drugs market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Thrombosis drugs can help thin the blood and help dissolve blood clots. It can also slow down the formation of blood clots and help treat thrombotic diseases.
Influence of COVID-19 Outbreak on Thrombosis Drugs Industry Development
Due to the global outbreak of COVID-19, many countries have adopted strict lockdown measures, and many companies have adopted home office work. For the thrombosis drug industry, COVID-19 has affected the supply chain and industrial chain to a certain extent. COVID-19 may have affected the supply of upstream raw materials. At the same time, working from home and many pharmaceutical industries have shifted their research focus to the treatment of COVID-19, resulting in a shortage of professionals in the thrombosis drug industry. In addition, because the virus may spread through the logistics and transportation links, the inspection of logistics is stricter, which slows down the logistics and affects the delivery time and production cycle of thrombosis drugs.
Due to the COVID-19 lockdown measures, people have reduced the number of outings. Sedentary and lack of exercise are particularly noticeable during the COVID-19 lockdown. When a person accumulates blood during periods of inactivity, deep vein thrombosis can form and thicken into a blood clot. It is more likely to occur in the lower part of the body, but it may also occur in the arms or other areas. In severe cases, it may even form a pulmonary embolism. Therefore, during the COVID-19 blockade, people need to pay more attention to exercise at home, otherwise the risk of thrombosis may increase.
Drivers
Thrombosis is an abnormal blood clot in an artery or vein. Thrombosis drugs are used to prevent or treat blood clots that can cause different thrombotic events. The North American market occupies an important position in the thrombosis drug industry.
First of all, North America has a developed economy and attracts immigrants from all over the world. At the same time, the population of North America is aging. Coupled with the fast-paced lifestyle and eating habits in North America, the number of cardiovascular diseases and obesity in North America has increased rapidly. These diseases increase the risk of thrombosis, which promotes the development of the thrombosis drug industry in North America.
In addition, North America is the most economically and technologically developed region, with high income and consumption levels of residents. Coupled with the health care system and complete infrastructure, it is conducive to reimbursement of various thrombosis expenses and promotes the North American market. At the same time, the North American region has always attracted technical personnel from various industries, so that the region has an excellent talent pool to support the development of the industry. It is expected that the thrombosis drug industry in North America will continue to develop.
Region Overview:
Europe had the highest growth rate of all regions.
Company Overview:
Bayer AG is one of the major players operating in the Thrombosis Drugs market, holding a share of 16.21% in 2021.
Bayer AG manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
Bristol-Myers Squibb Company is a global biopharmaceutical company. Bristol Myers Squibb focuses on products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
Segmentation Overview:
Among different product types, Factor Xa Inhibitor segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Deep Vein Thrombosis segment occupied the biggest share from 2017 to 2022.
The Thrombosis Drugs market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Thrombosis Drugs market covered in Chapter 4:
LEO Pharma
Aspen Pharmacare Holdings Limited
Bayer AG
Chiesi
Boehringer Ingelheim GmbH
Sanofi SA
Daiichi Sankyo
Bristol-Myers Squibb
AstraZeneca PLC
Johnson & Johnson
ANGDE
Pfizer Inc.
In Chapter 12 and Chapter 14.1, on the basis of types, the Thrombosis Drugs market from 2018 to 2028 is primarily split into:
Factor Xa Inhibitor
Low Molecular Weight Heparin
P2Y12 Platelet Inhibitor
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Thrombosis Drugs market from 2018 to 2028 covers:
Pulmonary Embolism
Atrial Fibrillation
Deep Vein Thrombosis
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Thrombosis Drugs market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Thrombosis Drugs market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Thrombosis Drugs industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Thrombosis Drugs industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Thrombosis Drugs market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Thrombosis Drugs market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Thrombosis Drugs market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Thrombosis Drugs market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
